Boston Scientific (NYSE:BSX – Get Free Report) had its price objective boosted by analysts at Argus from $69.00 to $80.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the medical equipment provider’s stock. Argus’ price target points to a potential upside of […]
CPA Asset Management LLC decreased its stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 18.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,968 shares of the medical equipment provider’s stock after selling 1,092 shares during the period. CPA […]
Premier Path Wealth Partners LLC acquired a new position in Boston Scientific Co. (NYSE:BSX – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 9,198 shares of the medical equipment provider’s stock, valued at approximately $514,000. Other large […]
Public Sector Pension Investment Board increased its position in Boston Scientific Co. (NYSE:BSX – Free Report) by 23.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,016,903 shares of the medical equipment provider’s stock after buying an additional 192,535 […]
The company reported revenue of $3.7 billion and adjusted earnings of $0.55 per share, compared to the consensus estimates of $3.6 billion and $0.51, respectively.